Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Chemical Biology
  4. Volume 18, Issue 4
  5. Article
Volume 18, Issue 4
  • ISSN: 2212-7968
  • E-ISSN: 1872-3136

Abstract

Introduction/Objective

The use of lacatomtom (LTT), a psychoactive mixture of tomtom (TT) candies with lacasera (LC) beverage, has recently increased among young Nigerians and Africans. There isn't much scientific study on the constituent and effects of this psychoactive substance.

Methods

Herein, LTT was chemically-profiled using GCMS analysis, and the toxicological effects were examined in albino rats. experiment consists of five groups of six rats each (group 2 - LTT ; groups 1, 3, & 4 - TTT, TT, LC (1 mL) mg/mL kg/body weight once/day respectively, group 5 - distilled water ). Identified constituents were examined against human monoamine oxidase (MOA) and human catechol O-methyltransferase (COMT) using methods.

Results

Forty-seven chemical compounds were identified. intake of LTT elevated plasma alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, creatinine, total cholesterol, and LDL-cholesterol levels. The docked poses, binding scores, and interactions with amino acids informed the selection of (4-Methoxymethoxy-hex-5-ynylidene)-cyclohexane (MM) (-9.4 kcal/mol) and 3-(hydroxyphenylmethyl)-3,4-dimethyl-1-phenylpentan-2-one (HP) for COMT (-9.4 kcal/mol), while propionylcodeine (-10.1 kcal/mol) and HP (-8.9 kcal/mol) for MOA. Top-docked compounds (TDC) demonstrated the potential to permeate the blood-brain barrier. TDC was predicted to be a positive substrate of the P-glycoprotein and presents inhibitory potential for cytochrome P descriptors. HP was mutagenic and could induce human hepatotoxicity and drug-induced liver injury, while propionylcodeine had a human hepatotoxic prediction.

Conclusion

The present study, for the first time, confirmed the potential toxicity of lacatomtom to the liver, kidney, heart, and central nervous system supported by the identified top-docked compounds regarded as potential psychoactive constituents of MOA and COMT.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccb/10.2174/0122127968319253241024050426
2024-11-04
2025-03-01

  • From This Site

    /content/journals/ccb/10.2174/0122127968319253241024050426
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PeacockA. BrunoR. GisevN. DegenhardtL. HallW. SedefovR. WhiteJ. ThomasK.V. FarrellM. GriffithsP. New psychoactive substances: Challenges for drug surveillance, control, and public health responses.Lancet2019394102091668168410.1016/S0140‑6736(19)32231‑731668410
     [Google Scholar]
  2. Mirian AguochaC. NwefohE. Prevalence and correlates of substance use among undergraduates in a developing country.Afr. Health Sci.202121287588310.4314/ahs.v21i2.4934795747
     [Google Scholar]
  3. DegenhardtL. ChiuW.T. SampsonN. KesslerR.C. AnthonyJ.C. AngermeyerM. BruffaertsR. de GirolamoG. GurejeO. HuangY. KaramA. KostyuchenkoS. LepineJ.P. MoraM.E.M. NeumarkY. OrmelJ.H. Pinto-MezaA. Posada-VillaJ. SteinD.J. TakeshimaT. WellsJ.E. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys.PLoS Med.200857e14110.1371/journal.pmed.005014118597549
     [Google Scholar]
  4. YusufFA Factors Influencing Substance Abuse among Undergraduate Students in Osun State, Nigeria.African Res. Rev.20114469233
     [Google Scholar]
  5. LapsleyD.K. EdgertonJ. Separation‐individuation, adult attachment style, and college adjustment.J. Couns. Dev.200280448449210.1002/j.1556‑6678.2002.tb00215.x
     [Google Scholar]
  6. AdesidaS.A. QuadriM.O. AdedejiA.M. Use of psychoactive substances among students in a Nigerian University: An imperative for intervention programs.Sci. Am.202216e01139
     [Google Scholar]
  7. OluwafunmilayoO.V. JohnO.O. OlabodeO.N. BlessingA.O. ManirambonaE. VicerraP.M.M. Prevalence and pattern of psychoactive substance use among government secondary school students in central Nigeria.PAMJ-One Health202220228
     [Google Scholar]
  8. OnaolapoO.J. OlofinnadeA.T. OjoF.O. AdeleyeO. FaladeJ. OnaolapoA.Y. Substance use and substance use disorders in Africa: An epidemiological approach to the review of existing literature.World J. Psychiatry202212101268128610.5498/wjp.v12.i10.126836389088
     [Google Scholar]
  9. MustaphaA.K. Codeine: Addicts now use lacasera, tomtom to form “gigabyte” solution-NDLEA.2018Available From: https://peoplesdailyng.com/codeine-addicts-now-use-lacasera-tomtom-to-form-gigabyte-solution-ndlea
  10. KuntzlemanT.S. DavenportL.S. CothranV.I. KuntzlemanJ.T. CampbellD.J. New demonstrations and new insights on the mechanism of the Candy-Cola soda geyser.J. Chem. Educ.201794556957610.1021/acs.jchemed.6b00862
     [Google Scholar]
  11. AlexandridouA. MouskeftaraT. RaikosN. GikaH.G. GC-MS analysis of underivatised new psychoactive substances in whole blood and urine.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2020115612230810.1016/j.jchromb.2020.12230833038866
     [Google Scholar]
  12. YuW MacKerellAD Computer-aided drug design methods.Methods Mol. Biol.201715208510610.1007/978‑1‑4939‑6634‑9_5
     [Google Scholar]
  13. LeeK. KimD. In-silico molecular binding prediction for human drug targets using deep neural multi-task learning.Genes (Basel)2019101190610.3390/genes1011090631703452
     [Google Scholar]
  14. HalperinI. MaB. WolfsonH. NussinovR. Principles of docking: An overview of search algorithms and a guide to scoring functions.Proteins200247440944310.1002/prot.1011512001221
     [Google Scholar]
  15. HassanS.S. AbbasS.Q. AliF. IshaqM. BanoI. HassanM. JinH.Z. BungauS.G. A Comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of vieloplain F from Xylopia vielana Targeting B-Raf Kinase.Molecules202227391710.3390/molecules2703091735164181
     [Google Scholar]
  16. DuarteP CuadradoA LeónR. Monoamine oxidase inhibitors: From classic to new clinical approaches.Handb Exp Pharmacol.2021264229259
     [Google Scholar]
  17. MorrisG.M. HueyR. LindstromW. SannerM.F. BelewR.K. GoodsellD.S. OlsonA.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.J. Comput. Chem.200930162785279110.1002/jcc.2125619399780
     [Google Scholar]
  18. O’BoyleN.M. BanckM. JamesC.A. MorleyC. VandermeerschT. HutchisonG.R. Open Babel: An open chemical toolbox.J. Cheminform.2011313310.1186/1758‑2946‑3‑3321982300
     [Google Scholar]
  19. TrottO. OlsonA.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.J. Comput. Chem.201031245546110.1002/jcc.2133419499576
     [Google Scholar]
  20. AbrahamM.J. MurtolaT. SchulzR. PállS. SmithJ.C. HessB. LindahlE. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers.SoftwareX20151-2192510.1016/j.softx.2015.06.001
     [Google Scholar]
  21. BrooksB.R. BrooksC.L.III MackerellA.D.Jr NilssonL. PetrellaR.J. RouxB. WonY. ArchontisG. BartelsC. BoreschS. CaflischA. CavesL. CuiQ. DinnerA.R. FeigM. FischerS. GaoJ. HodoscekM. ImW. KuczeraK. LazaridisT. MaJ. OvchinnikovV. PaciE. PastorR.W. PostC.B. PuJ.Z. SchaeferM. TidorB. VenableR.M. WoodcockH.L. WuX. YangW. YorkD.M. KarplusM. CHARMM: The biomolecular simulation program.J. Comput. Chem.200930101545161410.1002/jcc.2128719444816
     [Google Scholar]
  22. JoS. ChengX. IslamS.M. HuangL. RuiH. ZhuA. LeeH.S. QiY. HanW. VanommeslaegheK. MacKerellA.D.Jr RouxB. ImW. CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues.Adv. Protein Chem. Struct. Biol.20149623526510.1016/bs.apcsb.2014.06.00225443960
     [Google Scholar]
  23. JoS. A web-based graphical user interface for CHARMM SUNHWAN.J. Comput. Chem.2008291859186510.1002/jcc.2094518351591
     [Google Scholar]
  24. OgunyemiO.M. GyebiG.A. IbrahimI.M. EsanA.M. OlaiyaC.O. SolimanM.M. BatihaG.E.S. Identification of promising multi-targeting inhibitors of obesity from Vernonia amygdalina through computational analysis.Mol. Divers.202327112510.1007/s11030‑022‑10397‑635179699
     [Google Scholar]
  25. GyebiG.A. OgunyemiO.M. IbrahimI.M. AfolabiS.O. AdebayoJ.O. Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective.Comput. Biol. Med.202113410440610.1016/j.compbiomed.2021.10440633915479
     [Google Scholar]
  26. OgunyemiO.M. GyebiG.A. IbrahimI.M. OlaiyaC.O. OchejeJ.O. FabusiwaM.M. AdebayoJ.O. Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: A structure-based screening.RSC Advances20211153333803339810.1039/D1RA05976A35497510
     [Google Scholar]
  27. Valdés-TresancoM.S. Valdés-TresancoM.E. ValienteP.A. MorenoE. gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS.J. Chem. Theory Comput.202117106281629110.1021/acs.jctc.1c0064534586825
     [Google Scholar]
  28. MillerB.R.III McGeeT.D.Jr SwailsJ.M. HomeyerN. GohlkeH. RoitbergA.E. MMPBSA. py: An efficient program for end-state free energy calculations.J. Chem. Theory Comput.2012893314332110.1021/ct300418h26605738
     [Google Scholar]
  29. EmmanuelF.T. AkorS.E. MomohS. OwemiduI.O. AkorS.E. Investigation of the hepatotoxicity of lacatomtom drink in albino rat.Nigerian J. Biochem. Mol. Biol.2022372631
     [Google Scholar]
  30. KaplanA. The determination of urea, ammonia, and urease.Methods Biochem. Anal.19691731132410.1002/9780470110355.ch74893472
     [Google Scholar]
  31. JaffeA.S. SerotaH. GraceA. SobelB.E. Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction.Circulation198674110510910.1161/01.CIR.74.1.1053708769
     [Google Scholar]
  32. ReitmanS. FrankelS. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.Am. J. Clin. Pathol.1957281566310.1093/ajcp/28.1.5613458125
     [Google Scholar]
  33. DemetriousJ. Direct Colorimetric Determination of Alkaline Phosphatase in Serum. Enzymes in Clinical Chemistry, Principles and Techniques.2nd edHagerstownHarper and Row1974927
     [Google Scholar]
  34. AllainC.C. PoonL.S. ChanC.S.G. RichmondW. FuP.C. Enzymatic determination of total serum cholesterol.Clin. Chem.197420447047510.1093/clinchem/20.4.4704818200
     [Google Scholar]
  35. BucoloG. DavidH. Quantitative determination of serum triglycerides by the use of enzymes.Clin. Chem.197319547648210.1093/clinchem/19.5.4764703655
     [Google Scholar]
  36. GroveT.H. Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium.Clin. Chem.197925456056410.1093/clinchem/25.4.56038018
     [Google Scholar]
  37. GyebiG.A. OgunyemiO.M. AdefolaluA.A. Rodríguez-MartínezA. López-PastorJ.F. Banegas-LunaA.J. Pérez-SánchezH. AdegunloyeA.P. OgunroO.B. AfolabiS.O. African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2′-O-ribose methyltransferase: An in silico perspective.J. Mol. Struct.2022126213301910.1016/j.molstruc.2022.13301935431328
     [Google Scholar]
  38. Van HoutM.C. The dynamic landscape of novel psychoactive substance (NPS) use in Ireland: Results from an expert consultation.Int. J. Ment. Health Addict.201715598599210.1007/s11469‑016‑9714‑y
     [Google Scholar]
  39. PickeringL. GreenwoodS. New for who?: Novelty and continuity in drug-related practices of people who use new psychoactive substances.Contemp. Drug Probl.201946432334410.1177/0091450919885664
     [Google Scholar]
  40. DumbiliE.W. EbuenyiI.D. UgoezeK.C. New psychoactive substances in Nigeria: A call for more research in Africa.Emerging Trends in Drugs, Addictions, and Health2021110000810.1016/j.etdah.2021.100008
     [Google Scholar]
  41. TrezzaA. IovinelliD. SantucciA. PrischiF. SpigaO. An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors.Sci. Rep.20201011386610.1038/s41598‑020‑70863‑932807895
     [Google Scholar]
  42. CzarnotaS. JohannissenL.O. BaxterN.J. RummelF. WilsonA.L. CliffM.J. LevyC.W. ScruttonN.S. WalthoJ.P. HayS. Equatorial active site compaction and electrostatic reorganization in catechol-O-methyltransferase.ACS Catal.2019954394440110.1021/acscatal.9b0017431080692
     [Google Scholar]
  43. LernerC. Jakob-RoetneR. BuettelmannB. EhlerA. RudolphM. Rodríguez SarmientoR.M. Rodríguez Sarmiento RMa. Design of potent and druglike nonphenolic inhibitors for catechol O-methyltransferase derived from a fragment screening approach targeting the S-adenosyl-l-methionine pocket.J. Med. Chem.20165922101631017510.1021/acs.jmedchem.6b0092727685665
     [Google Scholar]
  44. MatsumotoM. WeickertC.S. AkilM. LipskaB.K. HydeT.M. HermanM.M. KleinmanJ.E. WeinbergerD.R. Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function.Neuroscience2003116112713710.1016/S0306‑4522(02)00556‑012535946
     [Google Scholar]
  45. SilvaM. CaroV. GuzmánC. PerryG. ArecheC. CornejoA. 1 - α-Synuclein and tau, two targets for dementia.Studies in Natural Products ChemistryAmsterdamElsevier2020
     [Google Scholar]
  46. GoldsteinR.Z. VolkowN.D. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex.Am. J. Psychiatry2002159101642165210.1176/appi.ajp.159.10.164212359667
     [Google Scholar]
  47. Arias-CarriónO. StamelouM. Murillo-RodríguezE. Menéndez-GonzálezM. PöppelE. Dopaminergic reward system: A short integrative review.Int. Arch. Med.2010312410.1186/1755‑7682‑3‑2420925949
     [Google Scholar]
  48. HymanS.E. MalenkaR.C. NestlerE.J. Neural mechanisms of addiction: The role of reward-related learning and memory.Annu. Rev. Neurosci.200629156559810.1146/annurev.neuro.29.051605.11300916776597
     [Google Scholar]
  49. AxelrodJ. TomchickR. Enzymatic O-methylation of epinephrine and other catechols.J. Biol. Chem.1958233370270510.1016/S0021‑9258(18)64731‑313575440
     [Google Scholar]
  50. LohoffF.W. WellerA.E. BlochP.J. NallA.H. FerraroT.N. KampmanK.M. PettinatiH.M. OslinD.W. DackisC.A. O’BrienC.P. BerrettiniW.H. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.Neuropsychopharmacology200833133078308410.1038/npp.2008.12618704099
     [Google Scholar]
  51. ScheggiaD SanninoS Luisa ScattoniM PapaleoF. COMT as a drug target for cognitive functions and dysfunctions.CNS Neurol Disord Drug Targets2012112092110.2174/187152712800672481
     [Google Scholar]
  52. CoolsR. D’EspositoM. Inverted-U-shaped dopamine actions on human working memory and cognitive control.Biol. Psychiatry20116912e113e12510.1016/j.biopsych.2011.03.02821531388
     [Google Scholar]
  53. FišarZ. Drugs related to monoamine oxidase activity.Prog. Neuropsychopharmacol. Biol. Psychiatry20166911212410.1016/j.pnpbp.2016.02.01226944656
     [Google Scholar]
  54. WagmannL. BrandtS.D. StratfordA. MaurerH.H. MeyerM.R. Interactions of phenethylamine‐derived psychoactive substances of the 2C‐series with human monoamine oxidases.Drug Test. Anal.201911231832410.1002/dta.249430188017
     [Google Scholar]
  55. GaweskaH FitzpatrickPF Structures and mechanism of the monoamine oxidase family.Biomol. Concepts20112536537710.1515/BMC.2011.030
     [Google Scholar]
  56. ChengX. IvanovI. Molecular Dynamics.Methods Mol. Biol.201292924328510.1007/978‑1‑62703‑050‑2_1123007433
     [Google Scholar]
  57. DongY. LiaoM. MengX. SomeroG.N. Structural flexibility and protein adaptation to temperature: Molecular dynamics analysis of malate dehydrogenases of marine molluscs.Proc. Natl. Acad. Sci. USA201811561274127910.1073/pnas.171891011529358381
     [Google Scholar]
  58. SinhaS. WangS.M. Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation.Comput. Struct. Biotechnol. J.20201872373610.1016/j.csbj.2020.03.01332257056
     [Google Scholar]
  59. PerezA. MorroneJ.A. SimmerlingC. DillK.A. Advances in free-energy-based simulations of protein folding and ligand binding.Curr. Opin. Struct. Biol.201636253110.1016/j.sbi.2015.12.00226773233
     [Google Scholar]
  60. KollmanP.A. MassovaI. ReyesC. KuhnB. HuoS. ChongL. LeeM. LeeT. DuanY. WangW. DoniniO. CieplakP. SrinivasanJ. CaseD.A. CheathamT.E.III Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models.Acc. Chem. Res.2000331288989710.1021/ar000033j11123888
     [Google Scholar]
  61. KimergårdA. FoleyM. DaveyZ. WadsworthE. DrummondC. DelucaP. The challenge of complex drug use: Associated use of codeine‐containing medicines and new psychoactive substances in a European cross‐sectional online population.Hum. Psychopharmacol.2017323e261110.1002/hup.261128597537
     [Google Scholar]
  62. GerostamoulosJ. BurkeM.P. DrummerO.H. Involvement of codeine in drug-related deaths.Am. J. Forensic Med. Pathol.199617432733510.1097/00000433‑199612000‑000118947360
     [Google Scholar]
  63. DainaA. ZoeteV. A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules.ChemMedChem201611111117112110.1002/cmdc.20160018227218427
     [Google Scholar]
  64. SapkotaK. MaoZ. SynowickiP. LieberD. LiuM. IkezuT. GautamV. MonaghanD.T. GluN2D N-methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: Implications for schizophrenia.J. Pharmacol. Exp. Ther.2016356370271110.1124/jpet.115.23039126675679
     [Google Scholar]
  65. DanemanR. PratA. The blood-brain barrier.Cold Spring Harb. Perspect. Biol.201571a02041210.1101/cshperspect.a02041225561720
     [Google Scholar]
  66. RaschiE. VasinaV. PoluzziE. De PontiF. The hERG K+ channel: Target and antitarget strategies in drug development.Pharmacol. Res.200857318119510.1016/j.phrs.2008.01.00918329284
     [Google Scholar]
  67. KratzJ.M. GrienkeU. ScheelO. MannS.A. RollingerJ.M. Natural products modulating the hERG channel: Heartaches and hope.Nat. Prod. Rep.201734895798010.1039/C7NP00014F28497823
     [Google Scholar]
  68. MullinerD. SchmidtF. StolteM. SpirklH.P. CzichA. AmbergA. Computational models for human and animal hepatotoxicity with a global application scope.Chem. Res. Toxicol.201629575776710.1021/acs.chemrestox.5b0046526914516
     [Google Scholar]
  69. WangN.N. HuangC. DongJ. YaoZ.J. ZhuM.F. DengZ.K. LvB. LuA-P. ChenA.F. CaoD-S. Predicting human intestinal absorption with modified random forest approach: A comprehensive evaluation of molecular representation, unbalanced data, and applicability domain issues.RSC Advances2017731190071901810.1039/C6RA28442F
     [Google Scholar]
  70. XuY. DaiZ. ChenF. GaoS. PeiJ. LaiL. Deep learning for drug-induced liver injury.J. Chem. Inf. Model.201555102085209310.1021/acs.jcim.5b0023826437739
     [Google Scholar]
  71. OkorieN. ObeaguE.I. AdeniranO.C. OnyemaA.S. AgwuU.U. Codeine Substitute Challenges Drug and Substance Abuse Controls in Nigeria: Histopathology Evaluations of Norvegicus rattus on Lacatomtom.J. Complem. Alternat. Med. Res.20221982210.9734/jocamr/2022/v19i130366
     [Google Scholar]
  72. IsojeE.F. OkoroI.O. Changes in Oxidative Stress Parameters in Wistar Rats Administered Soft Drink and Menthol Candy.J. Appl. Sci. Environ. Manag.202225122047205210.4314/jasem.v25i12.8
     [Google Scholar]
  73. ArikaW. NyamaiD. OsanoK. NgugiM. NjagiE. Biochemical markers of in vivo hepatotoxicity.J. Clin. Toxicol.20166297
     [Google Scholar]
  74. AniO UdediS AkpataE EzeigweO OguazuC OnyishiC Effects of ethanol leaf extract of Justicia carnea on biochemical indices of alloxan-induced diabetic rats.Seman. Sch.2011
     [Google Scholar]
  75. JahnaviN. NaiduP. RaoK. KarunasreeC. Antihyperlipidemic effect of Asparagus gonnoclados baker against cholesterol diet induced hyperlipidemia in rats.Asian J. Pharm. Clin. Res.20147212215
     [Google Scholar]
  76. ShahidS.U. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects.Lipids Health Dis.20201917
     [Google Scholar]
/content/journals/ccb/10.2174/0122127968319253241024050426
Loading
Chemical Profiling, In-Silico Investigation and In Vivo Toxicity Assessment of Lacatomtom (A Psychoactive Mixture) on Selected Indices in Albino Wistar Rats
Curr Chem Biol 18, 215 (2024); https://doi.org/10.2174/0122127968319253241024050426
/content/journals/ccb/10.2174/0122127968319253241024050426
/content/journals/ccb/10.2174/0122127968319253241024050426
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): ADMET analysis; catechol O-methyltransferase; Lacatomtom; liver function test; molecular docking; monoamine oxidase

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test